Market Cap

Genky DrugStores Co. Ltd Market Capitalization:

¥84.98 Billion

JPY as of July 1, 2024

US$526.3 Million

business Genky DrugStores Co. Ltd Company Profile

Genky DrugStores Co. Ltd Main Stock Listing

JPX: 9267

Market Capitalization History of Genky DrugStores Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Pharmaceutical Retailers
Company Market Cap (USD)
Conversion Labs, Inc. $51.29 B
Walgreens Boots Alliance, Inc. $9.58 B
Raia Drogasil SA $7.62 B
Alibaba Health Information Technology Ltd $6.63 B
Matsumotokiyoshi Holdings Co. Ltd $6.16 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Genky DrugStores Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 ¥82.01 B 50.89%
Jan. 1, 2023 ¥54.35 B 1.67%
Jan. 1, 2022 ¥53.46 B -5.53%
Jan. 1, 2021 ¥56.59 B 90.42%
Jan. 1, 2020 ¥29.72 B -23.38%
Jan. 1, 2019 ¥38.79 B -29.51%
Jan. 1, 2018 ¥55.02 B 19.42%
Jan. 1, 2017 ¥46.08 B 119.93%
Jan. 1, 2016 ¥20.95 B -41.21%
Jan. 1, 2015 ¥35.64 B 316.01%
Jan. 1, 2014 ¥8.57 B 9.85%
Jan. 1, 2013 ¥7.80 B 26.86%
Jan. 1, 2012 ¥6.15 B 32.03%
Jan. 1, 2011 ¥4.66 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Genky DrugStores Co. Ltd Categories

Japan languages Healthcare languages Pharmaceutical Retailers
Japan Healthcare Japan Pharmaceutical Retailers

Stocks & Indices

Genky DrugStores Co. Ltd has the following listings and related stock indices.


Stock: JPX: 9267

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.